Evidence map›Paper›PMID 35342834›Full record

ArticleHeliyon2022

Single dose oral pharmacokinetic profile rubraxanthone in mice.

Meri Susanti, Riski Darmianti, Yahdiana Harahap, Afrizal Itam, Dachriyanus Hamidi

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Meri SusantiFaculty of Pharmacy, Universitas Andalas, Padang, West Sumatra, 25163, Indonesia.
Riski DarmiantiFaculty of Pharmacy, Universitas Andalas, Padang, West Sumatra, 25163, Indonesia.
Yahdiana HarahapFaculty of Pharmacy, Universitas Indonesia, Depok, West Java, Indonesia.
Afrizal ItamDepartment of Chemistry, FMIPA, Universitas Andalas, Padang, West Sumatra, 25163, Indonesia.
Dachriyanus HamidiFaculty of Pharmacy, Universitas Andalas, Padang, West Sumatra, 25163, Indonesia.
Andalas University · IDUniversity of Indonesia · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rubraxanthone is a main active constituent of kandis (

Indexed as

BioanalysisPharmacokineticRubraxanthoneUHPLCValidation

Identifiers

PMID35342834
PMCPMC8941156
OpenAlexW4220659337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.